Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Maxigen Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

NT$811.6 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue427.7M452.2M457.7M512.0M604.4M622.1M680.7M811.6M
Cost of goods sold218.9M202.4M210.0M218.0M200.9M170.4M170.3M215.7M
Gross profit209.2M250.2M247.9M305.4M404.7M452.4M511.4M600.6M
Gross profit margin, %55.3%54.2%59.6%67.0%72.7%75.1%74.0%
Operating expense total136.4M151.8M153.5M168.1M240.7M274.0M288.9M310.0M
Depreciation and amortization26.2M32.5M33.2M32.9M29.6M27.6M27.0M32.1M
EBITDA72.8M98.4M94.4M137.3M164.0M178.3M222.5M290.6M
EBITDA margin, %21.8%20.6%26.8%27.1%28.7%32.7%35.8%
EBIT51.4M80.2M81.6M103.8M135.7M150.6M195.4M258.5M
EBIT margin, %17.7%17.8%20.3%22.4%24.2%28.7%31.9%
Interest income3.5M4.5M775.0K481.0K3.2M12.3M9.7M10.0M
Interest expense4.0M3.4M250.0K196.0K68.0K43.0K
Pre tax profit57.3M72.8M76.7M97.5M165.8M193.1M225.5M304.9M
Income tax expense253.0K12.7M13.4M9.8M26.4M27.3M35.4M39.6M
Net Income57.1M60.1M63.3M87.7M139.4M165.8M190.2M265.3M

Footer menu